1748225 Mirvetuximab soravtansina 5 mg/ml Sol inj Fr 20 ml IV Fim PAP custo Zero – Ano 2025 – Ano 2025

ID 11979958 · Portal BASE
Price
Base Price
€73,626 .00
Effective Price
€73,626 .00 0.0%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Porto, Vila Nova de Gaia Portugal, Porto, Vila Nova de Gaia
Bidder Count
—
Winner
ABBVIE, LDA
NIF 510229050
Company
Dates
Publication
26 Nov 2025
Celebration
26 Nov 2025
Contracting Entity
Centro Hospitalar Vila Nova de Gaia - Espinho, EPE
NIF 508142156
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 35 · MEDIUM RISK
A5 · Threshold Splitting
A5_THRESHOLD_SPLITTING
MEDIUM
Base price
73626.0
Threshold
75000.0
Rule
A5 threshold splitting: price within 5% below 75000.0
Detected 2026-03-06